The global market for Cell Line STR Testing was valued at US$ 356 million in the year 2024 and is projected to reach a revised size of US$ 568 million by 2031, growing at a CAGR of 7.0% during the forecast period.
Verifying the identity and purity of human cell lines is essential to the integrity of research activities. Companies in the cell line authentication and characterization tests market are increasing R&D in human cell authentication assays that identify short term repeat (STR) markers. Stakeholders in the cell line authentication and characterization tests market are making use of multiplex听polymerase chain reaction听(PCR) to simultaneously amplify the amelogenin gene and some of the most informative polymorphic markers in the human genome.
North American market for Cell Line STR Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cell Line STR Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Cell Line STR Testing in Microbial Contamination is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Cell Line STR Testing include Bio-Synthesis, Inc., Cell Line Genetics, Inc., Charles River Laboratories, DNA Forensics Lab India, Eurofins Genomics (Eurofins Scientific), GenomeScan, IDEXX Laboratories, Inc., Laboratory Corporation of America Holdings, Microsynth AG, NorthGene Limited (Biofortuna Limited), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cell Line STR Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Line STR Testing.
The Cell Line STR Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cell Line STR Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell Line STR Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-Synthesis, Inc.
Cell Line Genetics, Inc.
Charles River Laboratories
DNA Forensics Lab India
Eurofins Genomics (Eurofins Scientific)
GenomeScan
IDEXX Laboratories, Inc.
Laboratory Corporation of America Holdings
Microsynth AG
NorthGene Limited (Biofortuna Limited)
Perfectus Biomed Limited
Promega Corporation
SGS SA
Sigma-Aldrich Co. LLC. (Merck KGaA)
Thermo Fisher Scientific, Inc.
Segment by Type
Short Tandem Repeat (STR) Analysis
Single Nucleotide Polymorphism (SNP) Analysis
Others
Segment by Application
Microbial Contamination
Cell Line Identity
Genetic Stability
Virus Testing
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell Line STR Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Line STR Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Short Tandem Repeat (STR) Analysis
1.2.3 Single Nucleotide Polymorphism (SNP) Analysis
1.2.4 Others
1.3 Market by Application
1.3.1 Global Cell Line STR Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Microbial Contamination
1.3.3 Cell Line Identity
1.3.4 Genetic Stability
1.3.5 Virus Testing
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Line STR Testing Market Perspective (2020-2031)
2.2 Global Cell Line STR Testing Growth Trends by Region
2.2.1 Global Cell Line STR Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cell Line STR Testing Historic Market Size by Region (2020-2025)
2.2.3 Cell Line STR Testing Forecasted Market Size by Region (2026-2031)
2.3 Cell Line STR Testing Market Dynamics
2.3.1 Cell Line STR Testing Industry Trends
2.3.2 Cell Line STR Testing Market Drivers
2.3.3 Cell Line STR Testing Market Challenges
2.3.4 Cell Line STR Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Line STR Testing Players by Revenue
3.1.1 Global Top Cell Line STR Testing Players by Revenue (2020-2025)
3.1.2 Global Cell Line STR Testing Revenue Market Share by Players (2020-2025)
3.2 Global Top Cell Line STR Testing Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cell Line STR Testing Revenue
3.4 Global Cell Line STR Testing Market Concentration Ratio
3.4.1 Global Cell Line STR Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Line STR Testing Revenue in 2024
3.5 Global Key Players of Cell Line STR Testing Head office and Area Served
3.6 Global Key Players of Cell Line STR Testing, Product and Application
3.7 Global Key Players of Cell Line STR Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Line STR Testing Breakdown Data by Type
4.1 Global Cell Line STR Testing Historic Market Size by Type (2020-2025)
4.2 Global Cell Line STR Testing Forecasted Market Size by Type (2026-2031)
5 Cell Line STR Testing Breakdown Data by Application
5.1 Global Cell Line STR Testing Historic Market Size by Application (2020-2025)
5.2 Global Cell Line STR Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cell Line STR Testing Market Size (2020-2031)
6.2 North America Cell Line STR Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cell Line STR Testing Market Size by Country (2020-2025)
6.4 North America Cell Line STR Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell Line STR Testing Market Size (2020-2031)
7.2 Europe Cell Line STR Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cell Line STR Testing Market Size by Country (2020-2025)
7.4 Europe Cell Line STR Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Line STR Testing Market Size (2020-2031)
8.2 Asia-Pacific Cell Line STR Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cell Line STR Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Cell Line STR Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell Line STR Testing Market Size (2020-2031)
9.2 Latin America Cell Line STR Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cell Line STR Testing Market Size by Country (2020-2025)
9.4 Latin America Cell Line STR Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Line STR Testing Market Size (2020-2031)
10.2 Middle East & Africa Cell Line STR Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cell Line STR Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Cell Line STR Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Synthesis, Inc.
11.1.1 Bio-Synthesis, Inc. Company Details
11.1.2 Bio-Synthesis, Inc. Business Overview
11.1.3 Bio-Synthesis, Inc. Cell Line STR Testing Introduction
11.1.4 Bio-Synthesis, Inc. Revenue in Cell Line STR Testing Business (2020-2025)
11.1.5 Bio-Synthesis, Inc. Recent Development
11.2 Cell Line Genetics, Inc.
11.2.1 Cell Line Genetics, Inc. Company Details
11.2.2 Cell Line Genetics, Inc. Business Overview
11.2.3 Cell Line Genetics, Inc. Cell Line STR Testing Introduction
11.2.4 Cell Line Genetics, Inc. Revenue in Cell Line STR Testing Business (2020-2025)
11.2.5 Cell Line Genetics, Inc. Recent Development
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Details
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories Cell Line STR Testing Introduction
11.3.4 Charles River Laboratories Revenue in Cell Line STR Testing Business (2020-2025)
11.3.5 Charles River Laboratories Recent Development
11.4 DNA Forensics Lab India
11.4.1 DNA Forensics Lab India Company Details
11.4.2 DNA Forensics Lab India Business Overview
11.4.3 DNA Forensics Lab India Cell Line STR Testing Introduction
11.4.4 DNA Forensics Lab India Revenue in Cell Line STR Testing Business (2020-2025)
11.4.5 DNA Forensics Lab India Recent Development
11.5 Eurofins Genomics (Eurofins Scientific)
11.5.1 Eurofins Genomics (Eurofins Scientific) Company Details
11.5.2 Eurofins Genomics (Eurofins Scientific) Business Overview
11.5.3 Eurofins Genomics (Eurofins Scientific) Cell Line STR Testing Introduction
11.5.4 Eurofins Genomics (Eurofins Scientific) Revenue in Cell Line STR Testing Business (2020-2025)
11.5.5 Eurofins Genomics (Eurofins Scientific) Recent Development
11.6 GenomeScan
11.6.1 GenomeScan Company Details
11.6.2 GenomeScan Business Overview
11.6.3 GenomeScan Cell Line STR Testing Introduction
11.6.4 GenomeScan Revenue in Cell Line STR Testing Business (2020-2025)
11.6.5 GenomeScan Recent Development
11.7 IDEXX Laboratories, Inc.
11.7.1 IDEXX Laboratories, Inc. Company Details
11.7.2 IDEXX Laboratories, Inc. Business Overview
11.7.3 IDEXX Laboratories, Inc. Cell Line STR Testing Introduction
11.7.4 IDEXX Laboratories, Inc. Revenue in Cell Line STR Testing Business (2020-2025)
11.7.5 IDEXX Laboratories, Inc. Recent Development
11.8 Laboratory Corporation of America Holdings
11.8.1 Laboratory Corporation of America Holdings Company Details
11.8.2 Laboratory Corporation of America Holdings Business Overview
11.8.3 Laboratory Corporation of America Holdings Cell Line STR Testing Introduction
11.8.4 Laboratory Corporation of America Holdings Revenue in Cell Line STR Testing Business (2020-2025)
11.8.5 Laboratory Corporation of America Holdings Recent Development
11.9 Microsynth AG
11.9.1 Microsynth AG Company Details
11.9.2 Microsynth AG Business Overview
11.9.3 Microsynth AG Cell Line STR Testing Introduction
11.9.4 Microsynth AG Revenue in Cell Line STR Testing Business (2020-2025)
11.9.5 Microsynth AG Recent Development
11.10 NorthGene Limited (Biofortuna Limited)
11.10.1 NorthGene Limited (Biofortuna Limited) Company Details
11.10.2 NorthGene Limited (Biofortuna Limited) Business Overview
11.10.3 NorthGene Limited (Biofortuna Limited) Cell Line STR Testing Introduction
11.10.4 NorthGene Limited (Biofortuna Limited) Revenue in Cell Line STR Testing Business (2020-2025)
11.10.5 NorthGene Limited (Biofortuna Limited) Recent Development
11.11 Perfectus Biomed Limited
11.11.1 Perfectus Biomed Limited Company Details
11.11.2 Perfectus Biomed Limited Business Overview
11.11.3 Perfectus Biomed Limited Cell Line STR Testing Introduction
11.11.4 Perfectus Biomed Limited Revenue in Cell Line STR Testing Business (2020-2025)
11.11.5 Perfectus Biomed Limited Recent Development
11.12 Promega Corporation
11.12.1 Promega Corporation Company Details
11.12.2 Promega Corporation Business Overview
11.12.3 Promega Corporation Cell Line STR Testing Introduction
11.12.4 Promega Corporation Revenue in Cell Line STR Testing Business (2020-2025)
11.12.5 Promega Corporation Recent Development
11.13 SGS SA
11.13.1 SGS SA Company Details
11.13.2 SGS SA Business Overview
11.13.3 SGS SA Cell Line STR Testing Introduction
11.13.4 SGS SA Revenue in Cell Line STR Testing Business (2020-2025)
11.13.5 SGS SA Recent Development
11.14 Sigma-Aldrich Co. LLC. (Merck KGaA)
11.14.1 Sigma-Aldrich Co. LLC. (Merck KGaA) Company Details
11.14.2 Sigma-Aldrich Co. LLC. (Merck KGaA) Business Overview
11.14.3 Sigma-Aldrich Co. LLC. (Merck KGaA) Cell Line STR Testing Introduction
11.14.4 Sigma-Aldrich Co. LLC. (Merck KGaA) Revenue in Cell Line STR Testing Business (2020-2025)
11.14.5 Sigma-Aldrich Co. LLC. (Merck KGaA) Recent Development
11.15 Thermo Fisher Scientific, Inc.
11.15.1 Thermo Fisher Scientific, Inc. Company Details
11.15.2 Thermo Fisher Scientific, Inc. Business Overview
11.15.3 Thermo Fisher Scientific, Inc. Cell Line STR Testing Introduction
11.15.4 Thermo Fisher Scientific, Inc. Revenue in Cell Line STR Testing Business (2020-2025)
11.15.5 Thermo Fisher Scientific, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Bio-Synthesis, Inc.
Cell Line Genetics, Inc.
Charles River Laboratories
DNA Forensics Lab India
Eurofins Genomics (Eurofins Scientific)
GenomeScan
IDEXX Laboratories, Inc.
Laboratory Corporation of America Holdings
Microsynth AG
NorthGene Limited (Biofortuna Limited)
Perfectus Biomed Limited
Promega Corporation
SGS SA
Sigma-Aldrich Co. LLC. (Merck KGaA)
Thermo Fisher Scientific, Inc.
听
听
*If Applicable.
